ANIKA THERAPEUTICS, INC.

Company

Anika Therapeutics, Inc.

Filed

August 17, 2023

Accession Number

0000902664-23-004496

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →